Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin

Siddharth Verma, Shumei Kato, Ronald Blum, Ilan Shapira, Patricia Friedmann, Mala Varma

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Unfractionated heparin (UFH) therapy is commonly used for the management of acute coronary syndrome (ACS), atrial fibrillation (AF) or atrial flutter (A-Flutter). Weight based heparin nomogram is widely used to determine the dosage of continuous intravenous infusion. Frequent monitoring is required due to the variable responses to its anticoagulant effects. We investigated factors that may influence the dose of UFH. We performed a retrospective cohort study of all patients who received continuous UFH for ACS, AF, or A-Flutter from January 2008 to December 2008 and reached maintenance dose of UFH within 48 hr. A total of 199 patients were included in this study: 42.7% were females and mean age was 66.6 ± 2.0 years. Univariate analysis revealed that age, gender, weight, serum albumin, and serum protein level were significantly associated with maintenance of UFH dose. After adjustment with multivariate analysis, age (R = -0.27, P ≤ 0.001), gender (R = -0.14, P ≤ 0.044), and weight (R = 0.54, P ≤ 0.001) remained to have significant association with maintenance UFH dose. In conclusion, we have identified not only weight but also age and gender as significant factors that may affect the maintenance of heparin dose in clinical setting.

Original languageEnglish (US)
Pages (from-to)624-626
Number of pages3
JournalAmerican Journal of Hematology
Volume85
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Heparin
Weights and Measures
Atrial Flutter
Maintenance
Acute Coronary Syndrome
Atrial Fibrillation
Nomograms
Intravenous Infusions
Serum Albumin
Anticoagulants
Blood Proteins
Cohort Studies
Multivariate Analysis
Retrospective Studies

ASJC Scopus subject areas

  • Hematology

Cite this

Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin. / Verma, Siddharth; Kato, Shumei; Blum, Ronald; Shapira, Ilan; Friedmann, Patricia; Varma, Mala.

In: American Journal of Hematology, Vol. 85, No. 8, 08.2010, p. 624-626.

Research output: Contribution to journalArticle

Verma, Siddharth ; Kato, Shumei ; Blum, Ronald ; Shapira, Ilan ; Friedmann, Patricia ; Varma, Mala. / Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin. In: American Journal of Hematology. 2010 ; Vol. 85, No. 8. pp. 624-626.
@article{04d3ba3b81764e1283d965b262865147,
title = "Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin",
abstract = "Unfractionated heparin (UFH) therapy is commonly used for the management of acute coronary syndrome (ACS), atrial fibrillation (AF) or atrial flutter (A-Flutter). Weight based heparin nomogram is widely used to determine the dosage of continuous intravenous infusion. Frequent monitoring is required due to the variable responses to its anticoagulant effects. We investigated factors that may influence the dose of UFH. We performed a retrospective cohort study of all patients who received continuous UFH for ACS, AF, or A-Flutter from January 2008 to December 2008 and reached maintenance dose of UFH within 48 hr. A total of 199 patients were included in this study: 42.7{\%} were females and mean age was 66.6 ± 2.0 years. Univariate analysis revealed that age, gender, weight, serum albumin, and serum protein level were significantly associated with maintenance of UFH dose. After adjustment with multivariate analysis, age (R = -0.27, P ≤ 0.001), gender (R = -0.14, P ≤ 0.044), and weight (R = 0.54, P ≤ 0.001) remained to have significant association with maintenance UFH dose. In conclusion, we have identified not only weight but also age and gender as significant factors that may affect the maintenance of heparin dose in clinical setting.",
author = "Siddharth Verma and Shumei Kato and Ronald Blum and Ilan Shapira and Patricia Friedmann and Mala Varma",
year = "2010",
month = "8",
doi = "10.1002/ajh.21751",
language = "English (US)",
volume = "85",
pages = "624--626",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin

AU - Verma, Siddharth

AU - Kato, Shumei

AU - Blum, Ronald

AU - Shapira, Ilan

AU - Friedmann, Patricia

AU - Varma, Mala

PY - 2010/8

Y1 - 2010/8

N2 - Unfractionated heparin (UFH) therapy is commonly used for the management of acute coronary syndrome (ACS), atrial fibrillation (AF) or atrial flutter (A-Flutter). Weight based heparin nomogram is widely used to determine the dosage of continuous intravenous infusion. Frequent monitoring is required due to the variable responses to its anticoagulant effects. We investigated factors that may influence the dose of UFH. We performed a retrospective cohort study of all patients who received continuous UFH for ACS, AF, or A-Flutter from January 2008 to December 2008 and reached maintenance dose of UFH within 48 hr. A total of 199 patients were included in this study: 42.7% were females and mean age was 66.6 ± 2.0 years. Univariate analysis revealed that age, gender, weight, serum albumin, and serum protein level were significantly associated with maintenance of UFH dose. After adjustment with multivariate analysis, age (R = -0.27, P ≤ 0.001), gender (R = -0.14, P ≤ 0.044), and weight (R = 0.54, P ≤ 0.001) remained to have significant association with maintenance UFH dose. In conclusion, we have identified not only weight but also age and gender as significant factors that may affect the maintenance of heparin dose in clinical setting.

AB - Unfractionated heparin (UFH) therapy is commonly used for the management of acute coronary syndrome (ACS), atrial fibrillation (AF) or atrial flutter (A-Flutter). Weight based heparin nomogram is widely used to determine the dosage of continuous intravenous infusion. Frequent monitoring is required due to the variable responses to its anticoagulant effects. We investigated factors that may influence the dose of UFH. We performed a retrospective cohort study of all patients who received continuous UFH for ACS, AF, or A-Flutter from January 2008 to December 2008 and reached maintenance dose of UFH within 48 hr. A total of 199 patients were included in this study: 42.7% were females and mean age was 66.6 ± 2.0 years. Univariate analysis revealed that age, gender, weight, serum albumin, and serum protein level were significantly associated with maintenance of UFH dose. After adjustment with multivariate analysis, age (R = -0.27, P ≤ 0.001), gender (R = -0.14, P ≤ 0.044), and weight (R = 0.54, P ≤ 0.001) remained to have significant association with maintenance UFH dose. In conclusion, we have identified not only weight but also age and gender as significant factors that may affect the maintenance of heparin dose in clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=77955501093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955501093&partnerID=8YFLogxK

U2 - 10.1002/ajh.21751

DO - 10.1002/ajh.21751

M3 - Article

VL - 85

SP - 624

EP - 626

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 8

ER -